Science

Scientists from NUST MISIS have found out how to improve the alloy for maxillofacial implants

Based on the experiments, scientists from NUST MISIS have identified a methodology that improves the balance of strength and ductility of the biodegradable magnesium alloy used in biomedicine, particularly for maxillofacial implants. The peculiarity of the material lies in the fact that after the operation, it gradually dissolves in the human body. Fixing elements (screws, pins, plates, etc.) made of magnesium alloy are completely replaced by newly formed tissue, eliminating the need for a second operation to remove temporary elements from the human body. In recent years, researchers have been interested in the magnesium, zinc, and gallium alloy (Mg-Zn-Ga). The addition of zinc and gallium improves the mechanical and corrosion properties, allowing the integrity of the implant to be maintained for a certain period necessary for the healing process. Zinc contributes to the strengthening of the material, while gallium enhances its ductility, imparts antimicrobial properties, and increases bone tissue density. Due to its characteristics, this alloy is much closer to human bone tissue than titanium.

Scientists from NUST MISIS have developed a neuroimplant for recovery from a spinal cord injury

Researchers from the MISIS University have created a prototype neuroimplant that could potentially help restore spinal cord damage. Further development of this device into a full-fledged therapy method may help restore motor and sensory functions to normal levels.

Researchers from the MISIS University have developed heat-resistant composites for the aviation and oil and gas industries

NUST MISIS researchers presented new heat-resistant composites based on aluminum alloy AA6063 for aviation and oil and gas complexes. Unlike conventional aluminum alloys, they are capable of operating at temperatures above 300°C.

Scientists from NUST MISIS proposed new wear-resistant coatings for the oil and gas industry

Researchers at NUST MISIS have developed a platform for detecting diseases at early stages

Scientists from the MISIS University, in collaboration with colleagues from Skoltech and the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, have developed a platform for detecting clinical biomarkers of diseases in human biological fluids in real-time. It could serve as the first step towards creating a portable lab-on-a-chip for early detection of cancer, neurodegenerative, and cardiovascular diseases, as well as for monitoring treatment.